Neil Kumar
Chief Executive Officer, Director at BridgeBio Pharma, Inc. (BBIO)
Neil Kumar has filed 89 insider reports with the SEC since February 2021, as chief Executive Officer and director at BridgeBio Pharma, Inc. (BBIO), director at BridgeBio Oncology Therapeutics, Inc. (BBOT) and director at Maze Therapeutics, Inc. (MAZE). In the last 12 months Neil Kumar sold $52.2M of stock on the open market. On November 18, 2026 Neil Kumar filed a Form 144 notice and plans to sell 34,980 BBIO shares (~$2.69M). The latest filing, on November 19, 2026, reports shares withheld for taxes or exercise price and exercise or conversion of a derivative at BridgeBio Pharma, Inc. (BBIO).
Planned sale (Form 144)
- Neil Kumar plans to sell 34,980 BBIO shares (~$2.69M), around Nov 18, 2026. Notice filed Nov 18, 2026.
A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.
- Filings
- 89
- Companies
- 3
- Bought on market
- None
- Sold on market
- $120M
Companies where Neil Kumar is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officer, Director | 278,307 | $120M | $78.01 | Nov 19, 2026 | |||
| Directorsince August 2025 | $1.805 | Jun 18, 2026 | |||||
| Directorsince March 2026 | $31.20 | Mar 31, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 16, 2026BBIOChief Executive Officer Neil Kumar converted options into 71,216 shares and covered exercise/tax liability with 36,236 shares, increasing direct ownership by 14% to 278,307 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Nov 18, 2026~$2.69MBBIONeil Kumar plans to sell 34,980 shares (~$2.69M)Form 144Planned sale10b5-1 plan
- Sep 17, 2026-$691KBBIOChief Executive Officer Kumar Neil sold $690,847 worth of shares (10,000 units at $69.08) as part of a pre-agreed trading planForm 4Open-market sale10b5-1 plan
- Aug 19, 2026-$3.73MBBIOChief Executive Officer Kumar Neil sold $3,727,251 worth of shares (44,980 units at $82.86) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 243,327 unitsForm 4Open-market sale10b5-1 plan
- Aug 19, 2026~$2.49MBBIONeil Kumar plans to sell 30,000 shares (~$2.49M)Form 144Planned sale10b5-1 plan
- Aug 16, 2026BBIOChief Executive Officer Kumar Neil converted options into 71,217 shares and covered exercise/tax liability with 36,237 shares, increasing direct ownership by 14% to 278,307 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Aug 18, 2026~$2.79MBBIONeil Kumar plans to sell 34,980 shares (~$2.79M)Form 144Planned sale10b5-1 plan
- Jun 16, 2026BBOTSEC Form 4 filed by Director Kumar NeilForm 4Grant or award
- Jun 5, 2026-$5.41MBBIOChief Executive Officer Kumar Neil sold $5,413,289 worth of shares (80,000 units at $67.67) as part of a pre-agreed trading planForm 4Open-market sale10b5-1 plan
- May 21, 2026-$1.81MBBIOChief Executive Officer Kumar Neil sold $1,812,522 worth of shares (26,103 units at $69.44) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 243,327 unitsForm 4Open-market sale10b5-1 plan
- May 21, 2026~$1.78MBBIONeil Kumar plans to sell 26,103 shares (~$1.78M)Form 144Planned sale10b5-1 plan
- May 16, 2026BBIOChief Executive Officer Kumar Neil converted options into 71,215 shares and covered exercise/tax liability with 36,236 shares, increasing direct ownership by 15% to 269,430 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- May 8, 2026-$5.39MBBIOChief Executive Officer Kumar Neil sold $5,392,243 worth of shares (80,000 units at $67.40) as part of a pre-agreed trading planForm 4Open-market sale10b5-1 plan
- Apr 10, 2026-$5.97MBBIOSEC Form 4 filed by Kumar NeilForm 4Open-market sale10b5-1 plan
- Apr 9, 2026~$8.9MBBIONeil Kumar plans to sell 120,000 shares (~$8.9M)Form 144Planned sale10b5-1 plan
- Mar 27, 2026MAZESEC Form 4 filed by Kumar NeilForm 4Grant or award
- Mar 27, 2026MAZENeil Kumar became an insiderForm 3New insider
- Mar 17, 2026BBIOSEC Form 4 filed by Kumar NeilForm 4Grant or award
- Mar 13, 2026-$5.5MBBIOChief Executive Officer Kumar Neil sold $5,501,068 worth of shares (80,000 units at $68.76)Form 4Open-market sale10b5-1 plan
- Mar 13, 2026~$9.52MBBIONeil Kumar plans to sell 140,000 shares (~$9.52M)Form 144Planned sale10b5-1 plan
- Feb 19, 2026-$2MBBIOChief Executive Officer Kumar Neil sold $2,002,717 worth of shares (28,053 units at $71.39), decreasing direct ownership by 11% to 234,451 unitsForm 4Open-market sale10b5-1 plan
- Feb 19, 2026~$2.07MBBIONeil Kumar plans to sell 28,053 shares (~$2.07M)Form 144Planned sale10b5-1 plan
- Feb 16, 2026BBIOChief Executive Officer Kumar Neil converted options into 64,698 shares and covered exercise/tax liability with 30,970 shares, increasing direct ownership by 15% to 262,504 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 11, 2026-$5.75MBBIOChief Executive Officer Kumar Neil sold $5,748,666 worth of shares (80,000 units at $71.86)Form 4Open-market sale10b5-1 plan
- Jan 9, 2026-$6.04MBBIOChief Executive Officer Kumar Neil sold $6,043,168 worth of shares (80,000 units at $75.54)Form 4Open-market sale10b5-1 plan
- Jan 8, 2026~$8.91MBBIONeil Kumar plans to sell 120,000 shares (~$8.91M)Form 144Planned sale10b5-1 plan
- Jan 8, 2026~$7.43MBBIONeil Kumar plans to sell 100,000 shares (~$7.43M)Form 144Planned sale10b5-1 plan
- Dec 15, 2025-$2.24MBBIOChief Executive Officer Kumar Neil converted options into 60,975 shares, covered exercise/tax liability with 30,964 shares and sold $2,239,902 worth of shares (30,011 units at $74.64)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 15, 2025~$2.26MBBIONeil Kumar plans to sell 30,011 shares (~$2.26M)Form 144Planned sale10b5-1 plan
- Dec 5, 2025-$5.91MBBIOChief Executive Officer Kumar Neil sold $5,908,476 worth of shares (80,000 units at $73.86)Form 4Open-market sale10b5-1 plan
- Nov 20, 2025-$1.72MBBIOChief Executive Officer Kumar Neil sold $1,722,224 worth of shares (26,156 units at $65.84), decreasing direct ownership by 10% to 228,776 unitsForm 4Open-market sale10b5-1 plan
- Nov 20, 2025~$1.71MBBIONeil Kumar plans to sell 26,156 shares (~$1.71M)Form 144Planned sale10b5-1 plan
- Nov 16, 2025BBIOChief Executive Officer Kumar Neil converted options into 64,697 shares and covered exercise/tax liability with 32,855 shares, increasing direct ownership by 14% to 254,932 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Nov 7, 2025-$4.98MBBIOChief Executive Officer Kumar Neil sold $4,983,111 worth of shares (80,000 units at $62.29)Form 4Open-market sale10b5-1 plan
- Oct 9, 2025-$4.38MBBIOChief Executive Officer Kumar Neil sold $4,383,442 worth of shares (80,000 units at $54.79)Form 4Open-market sale10b5-1 plan
- Oct 8, 2025~$6.51MBBIONeil Kumar plans to sell 120,000 shares (~$6.51M)Form 144Planned sale10b5-1 plan
- Oct 8, 2025~$6.51MBBIONeil Kumar plans to sell 120,000 shares (~$6.51M)Form 144Planned sale10b5-1 plan
- Sep 5, 2025-$4.18MBBIOChief Executive Officer Kumar Neil sold $4,175,835 worth of shares (80,000 units at $52.20)Form 4Open-market sale10b5-1 plan
- Aug 20, 2025-$1.28MBBIOChief Executive Officer Kumar Neil sold $1,276,927 worth of shares (26,156 units at $48.82), decreasing direct ownership by 10% to 223,090 unitsForm 4Open-market sale10b5-1 plan
- Aug 20, 2025~$1.28MBBIONeil Kumar plans to sell 26,156 shares (~$1.28M)Form 144Planned sale10b5-1 plan
- Aug 16, 2025BBIOChief Executive Officer Kumar Neil converted options into 64,697 shares and covered exercise/tax liability with 32,855 shares, increasing direct ownership by 15% to 249,246 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Aug 11, 2025BBOTNeil Kumar became an insiderForm 3New insider
- Aug 8, 2025-$3.67MBBIOChief Executive Officer Kumar Neil sold $3,666,949 worth of shares (80,000 units at $45.84)Form 4Open-market sale10b5-1 plan
- Jul 2, 2025-$3.41MBBIOChief Executive Officer Kumar Neil sold $3,410,450 worth of shares (80,000 units at $42.63)Form 4Open-market sale10b5-1 plan
- Jul 1, 2025~$5.18MBBIONeil Kumar plans to sell 120,000 shares (~$5.18M)Form 144Planned sale10b5-1 plan
- Jul 1, 2025~$5.18MBBIONeil Kumar plans to sell 120,000 shares (~$5.18M)Form 144Planned sale10b5-1 plan
- May 20, 2025-$3.38MBBIOChief Executive Officer Kumar Neil converted options into 64,696 shares, covered exercise/tax liability with 32,854 shares and sold $3,376,741 worth of shares (101,156 units at $33.38), increasing direct ownership by 3% to 217,404 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 19, 2025~$885KBBIONeil Kumar plans to sell 26,156 shares (~$885K)Form 144Planned sale10b5-1 plan
- Apr 22, 2025-$2.56MBBIOChief Executive Officer Kumar Neil sold $2,558,025 worth of shares (75,000 units at $34.11)Form 4Open-market sale10b5-1 plan
- Mar 25, 2025-$2.76MBBIOChief Executive Officer Kumar Neil sold $2,764,943 worth of shares (75,000 units at $36.87)Form 4Open-market sale10b5-1 plan
- Mar 19, 2025BBIOSEC Form 4 filed by Chief Executive Officer Kumar NeilForm 4Grant or award
- Feb 25, 2025-$2.52MBBIOChief Executive Officer Kumar Neil sold $2,517,971 worth of shares (75,000 units at $33.57)Form 4Open-market sale10b5-1 plan
- Feb 25, 2025~$10.9MBBIONeil Kumar plans to sell 300,000 shares (~$10.9M)Form 144Planned sale10b5-1 plan
- Feb 19, 2025-$1.14MBBIOChief Executive Officer Kumar Neil converted options into 55,539 shares, covered exercise/tax liability with 23,996 shares and sold $1,140,024 worth of shares (31,543 units at $36.14)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 19, 2025~$1.12MBBIONeil Kumar plans to sell 31,543 shares (~$1.12M)Form 144Planned sale10b5-1 plan
- Jan 29, 2025-$21.8MBBIOChief Executive Officer Kumar Neil sold $21,788,650 worth of shares (600,000 units at $36.31)Form 4Open-market sale10b5-1 plan
- Jan 28, 2025~$22MBBIONeil Kumar plans to sell 600,000 shares (~$22M)Form 144Planned sale10b5-1 plan
- Dec 24, 2024BBIOChief Executive Officer Kumar Neil gifted 4,685,725 shares and received a gift of 4,685,725 shares, decreasing direct ownership by 96% to 211,718 unitsForm 4Gift
- Dec 10, 2024BBIOSEC Form 4 filed by Chief Executive Officer Kumar NeilForm 4Grant or award
- Nov 19, 2024-$614KBBIOChief Executive Officer Kumar Neil sold $613,826 worth of shares (27,389 units at $22.41), decreasing direct ownership by 0.56% to 4,897,443 unitsForm 4Open-market sale10b5-1 plan
- Nov 16, 2024BBIOChief Executive Officer Kumar Neil converted options into 55,537 shares and covered exercise/tax liability with 28,148 shares, increasing direct ownership by 0.56% to 4,924,832 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Nov 19, 2024~$612KBBIONeil Kumar plans to sell 27,389 shares (~$612K)Form 144Planned sale10b5-1 plan
- Aug 19, 2024-$676KBBIOChief Executive Officer Kumar Neil converted options into 55,537 shares, covered exercise/tax liability with 28,148 shares and sold $676,256 worth of shares (27,389 units at $24.69)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 19, 2024~$668KBBIONeil Kumar plans to sell 27,389 shares (~$668K)Form 144Planned sale10b5-1 plan
- May 16, 2024BBIOKumar Neil converted options into 60,667 shares and covered exercise/tax liability with 30,748 shares, increasing direct ownership by 0.61% to 4,897,443 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 12, 2024BBIOSEC Form 4 filed by Kumar NeilForm 4Grant or award
- Feb 16, 2024BBIOKumar Neil converted options into 102,249 shares and covered exercise/tax liability with 47,922 shares, increasing direct ownership by 1% to 4,867,524 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Nov 17, 2023-$1.5MBBIOKumar Neil converted options into 102,249 shares, covered exercise/tax liability with 50,697 shares and sold $1,500,038 worth of shares (51,552 units at $29.10)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Nov 17, 2023~$1.49MBBIONeil Kumar plans to sell 51,552 shares (~$1.49M)Form 144Planned sale10b5-1 plan
- Aug 17, 2023-$1.47MBBIOSEC Form 4: Kumar Neil converted options into 102,250 shares, covered exercise/tax liability with 50,698 shares and sold $1,473,784 worth of shares (51,552 units at $28.59)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 17, 2023-$722KBBIOSEC Form 4 filed by Kumar NeilForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 3, 2023-$1.7MBBIOSEC Form 4 filed by Kumar NeilForm 4Open-market sale10b5-1 plan
- Apr 5, 2023-$1.86MBBIOSEC Form 4 filed by Kumar NeilForm 4Open-market sale10b5-1 plan
- Feb 17, 2023-$569KBBIOSEC Form 4: Kumar Neil converted options into 68,706 shares, covered exercise/tax liability with 23,908 shares and sold $569,073 worth of shares (44,798 units at $12.70) as part of a pre-agreed trading planForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 10, 2023BBIOSEC Form 4 filed by Kumar NeilForm 4Grant or award
- Feb 3, 2023-$1.32MBBIOSEC Form 4: Kumar Neil sold $1,320,696 worth of shares (120,000 units at $11.01) as part of a pre-agreed trading planForm 4Open-market sale10b5-1 plan
- Jan 5, 2023-$921KBBIOSEC Form 4: Kumar Neil sold $920,856 worth of shares (120,000 units at $7.67) as part of a pre-agreed trading planForm 4Open-market sale10b5-1 plan
- Dec 21, 2022BBIOSEC Form 4: Kumar Neil sold 200,000 sharesForm 4Open-market sale
- Nov 17, 2022-$326KBBIOSEC Form 4: Kumar Neil converted options into 68,706 shares, covered exercise/tax liability with 34,066 shares and sold $325,606 worth of shares (34,640 units at $9.40)Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale
- Aug 16, 2022BBIOSEC Form 4: Kumar Neil covered exercise/tax liability with 27,697 shares and converted options into 68,705 shares, increasing direct ownership by 0.86% to 4,813,197 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- May 16, 2022BBIOSEC Form 4: Kumar Neil converted options into 68,705 shares and covered exercise/tax liability with 23,759 shares, increasing direct ownership by 0.95% to 4,772,189 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 16, 2022BBIOSEC Form 4 filed by Kumar NeilForm 4Grant or award
- Feb 16, 2022BBIOSEC Form 4: Kumar Neil converted options into 7,524 shares and covered exercise/tax liability with 3,085 shares, increasing direct ownership by 0.09% to 4,727,243 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Dec 3, 2021BBIOSEC Form 4 filed by Kumar NeilForm 4Grant or award
- Nov 16, 2021BBIOSEC Form 4: Kumar Neil converted options into 7,523 shares and covered exercise/tax liability with 3,730 shares, increasing direct ownership by 0.08% to 4,722,804 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Aug 16, 2021BBIOSEC Form 4: Kumar Neil converted options into 7,523 units of Common Stock and covered exercise/tax liability with 3,730 units of Common Stock, increasing direct ownership by 0.08% to 4,719,011 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 17, 2021BBIOSEC Form 4: Neil Kumar exercised 5,129 units of Common Stock at a strike of $0.00 and disposed of $138,992 worth of Common Stock (2,139 units at $64.98), increasing ownership by 0.40% to 4,711,425 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 10, 2021BBIOSEC Form 4 filed by Neil KumarForm 4Grant or award
- Nov 24, 2020BBIOSEC Form 5: Neil Kumar gifted 472,650 units of Common Stock and received a gift of 268,000 units of Common StockForm 5Gift
Also sits on boards with
Officers and directors who share two or more companies with Neil Kumar.
- Charles J Homcy2 shared: BBIO, MAZE
- Frank Mccormick2 shared: BBIO, BBOT
- Richard H Scheller2 shared: MAZE, BBIO
Compare Neil Kumar with
- Neil Kumar vs Charles J Homcy2 shared
- Neil Kumar vs Frank Mccormick2 shared
- Neil Kumar vs Richard H Scheller2 shared
- Neil Kumar vs Thomas Trimarchi1 shared
- Neil Kumar vs Maricel Apuli1 shared
- Neil Kumar vs Marc Cobo1 shared
Other insiders at the same companies
- Thomas TrimarchiBBIO
- Maricel ApuliBBIO
- Marc CoboBBOT
- Jason V ColomaMAZE
- Harold BernsteinMAZE
- Atul DandekarMAZE
- Phillips CourtneyMAZE
- Sophie KornowskiMAZE
- Paula A JohnsonMAZE
- Randal W. ScottBBIO
- Andrea EllisBBIO
- Jennifer E. CookBBIO
- Idan ElmelechBBOT
- Pedro BeltranBBOT
- Yong BenBBOT
- Bihua ChenBBOT
Questions about Neil Kumar
- What is Neil Kumar's role at BridgeBio Pharma, Inc.?
- Neil Kumar reports to the SEC as chief Executive Officer and director at BridgeBio Pharma, Inc. (BBIO), according to the latest filing on November 19, 2026. Neil Kumar has also filed as director at BridgeBio Oncology Therapeutics, Inc. (BBOT) and director at Maze Therapeutics, Inc. (MAZE).
- How many shares does Neil Kumar own?
- After the latest filing that states it, Neil Kumar directly owned 278,307 shares of BridgeBio Pharma, Inc. (BBIO). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Neil Kumar bought or sold stock recently?
- The most recent open-market sale was on September 17, 2026: sold 10,000 shares of BridgeBio Pharma, Inc. (BBIO) for $691K at an average of $69.08.
- How do I get alerts when Neil Kumar files?
- Follow Neil Kumar on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Neil Kumar filed 3 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Neil Kumar (SEC CIK 0001742485). Totals count each trade once, skipping amendments whose original is on file, from Feb 12, 2021 on. View on SEC EDGAR